Colleen Jay to Risk Assessment
This is a "connection" page, showing publications Colleen Jay has written about Risk Assessment.
Connection Strength
0.199
-
Jay CL, Washburn K, Dean PG, Helmick RA, Pugh JA, Stegall MD. Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI Kidneys. Transplantation. 2017 Apr; 101(4):867-872.
Score: 0.096
-
Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, Feinglass J, Holl JL, Abecassis M, Skaro AI. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol. 2011 Oct; 55(4):808-13.
Score: 0.063
-
Skaro AI, Gallon LG, Lyuksemburg V, Jay CL, Zhao L, Ladner DP, VanWagner LB, De Wolf AM, Flaherty JD, Levitsky J, Abecassis MM, Gheorghiade M. The impact of coronary artery disease on outcomes after liver transplantation. J Cardiovasc Med (Hagerstown). 2016 Dec; 17(12):875-885.
Score: 0.023
-
Gordon EJ, Daud A, Caicedo JC, Cameron KA, Jay C, Fryer J, Beauvais N, Skaro A, Baker T. Informed consent and decision-making about adult-to-adult living donor liver transplantation: a systematic review of empirical research. Transplantation. 2011 Dec 27; 92(12):1285-96.
Score: 0.017